Article
Treatment of COVID-19 patients with a SARS-CoV-2-specific siRNA-peptide dendrimer formulation
2022-10-30
Abstract excerpt
BACKGROUND Severe acute respiratory syndrome corona virus (SARS-CoV-2) infection frequently causes severe and prolonged disease but only few specific treatments are available. We aimed to investigate safety and efficacy of a SARS-CoV-2-specific siRNA-peptide dendrimer formulation (MIR 19 ®) targeting a conserved sequence in known SARS-CoV-2 variants for treatment of COVID-19. METHODS We conducted an open-label, r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f8e8fbb8-0efb-5fee-b481-c6483c127e16
- DOI
- 10.22541/au.166713666.61935503/v1
